Marijuana: Neurotoxic or Neuroprotective?

Manoj Banjara

Authors

Manoj Banjara

Keywords:

marijuana, cannabinoids, neuroprotective, neurotoxic

Abstract

Chronic marijuana intake was known to induce morphological changes to the brain impairing memory and learning ability. However, several studies demonstrated the protective effect of marijuana post-brain traumas. This article reviews studies that strengthen our horizon to understand the effects of marijuana smoking in brain. This review predicts that optimum use of marijuana or pure marijuana compound can be beneficial or detrimental depending on the consumed dose.

Downloads

How to Cite

Marijuana: Neurotoxic or Neuroprotective?. (2015). Global Journal of Medical Research, 15(B2), 7-10. https://medicalresearchjournal.org/index.php/GJMR/article/view/877

Download Citation

References

Mary Abood, Gulrukh Rizvi, Neetha Sallapudi, Sean Mcallister (2001) Activation of the CB1 cannabinoid receptor protects cultured mouse spinal neurons against excitotoxicity. 309(3), 197-201.

Angela Ameri (1999) The effects of cannabinoids on the brain. 58(4), 315-348.

R Bash, V Rubovitch, M Gafni, Y Sarne (2003) The stimulatory effect of cannabinoids on calcium uptake is mediated by Gs GTP-binding proteins and cAMP formation. 12(1), 39-44.

R Block, O' Leary, D Ehrhardt, J Augustinack, J Ghoneim, M Arndt, S Hall, J (2000) Effects of frequent marijuana use on brain tissue volume and composition. 11(3), 491-496.

Antonio Calignano, Giovanna Rana, Andrea Giuffrida, Daniele Piomelli (1998) Control of pain initiation by endogenous cannabinoids. 394(6690), 277-281.

Elisaldo Carlini, Jomar Cunha (1981) Hypnotic and Antiepileptic Effects of Cannabidiol. 21(S1), 417S-427.

Guy Chiu-Kai Chan, Thomas Hinds, Soren Impey, Daniel Storm (1998) Hippocampal Neurotoxicity of Δ⁹-Tetrahydrocannabinol. 18(14), 5322-5332.

P Chan, R Sills, A Braun, J Haseman, J Bucher (1996) Toxicity and Carcinogenicity of Δ9-Tetrahydrocannabinol in Fischer Rats and B6C3F1 Mice. 30(1), 109-117.

J Court (1998) Cannabis and brain function. 34(1), 1-5.

K Fehr, H Kalant, A Leblanc, J Feigenbaum, F Bergmann, S Richmond, R Mechoulam, V Nadler, Y Kloog, M Sokolovsky (1976) Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker. 192(23), 9584-9587.

M Guzman, C Sanchez, I Galve-Roperh (2001) Control of the cell survival/death decision by cannabinoids. 78(11), 613-625.

A Hampson, M Grimaldi (2001) Cannabinoid receptor activation and elevated cyclic AMP reduce glutamate neurotoxicity. 13(8), 1529-1536.

Jon Harper, Robert Heath, William Myers (1977) Effects of cannabis sativa on ultrastructure of the synapse in monkey brain. 3(2), 87-93.

R Heath, A Fitzjarrell, C Fontana, R Garey (1980) Cannabis sativa: effects on brain function and ultrastructure in rhesus monkeys. 15(5), 657-690.

S Heishman, K Arasteh, M Stitzer (1997) Comparative effects of alcohol and marijuana on mood, memory, and performance. 58(1), 93-101.

C Heyser, R Hampson, S Deadwyler (1993) Effects of delta-9-tetrahydrocannabinol on delayed match to sample performance in rats: alterations in short-term memory associated with changes in task specific firing of hippocampal cells.. 264(1), 294-307.

L Hollister (1986) Health aspects of cannabis.. 38(1), 1-20.

R Karler, S Turkanis (1981) The cannabinoids as potential antiepileptics. 21(8-9), 437S-448.

P Landfield, L Cadwallader, S Vinsant (1988) Quantitative changes in hippocampal structure following long-term exposure to delta 9tetrahydrocannabinol: possible mediation by glucocorticoid systems. 443(1-2), 47-62.

J Lawston, A Borella, J Robinson, P Whitaker-Azmitia (2000) Changes in hippocampal morphology following chronic treatment with the synthetic cannabinoid WIN 55,212-2. 877(2), 407-410.

A Lichtman, B Martin (1996) Δ9-Tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism. 126(2), 125-131.

S Lukas, J Mendelson, R Benedikt (1995) Electroencephalographic correlates of marihuanainduced euphoria. 37(2), 131-140.

William Martin, Andrea Hohmann, J Walker (1996) Suppression of Noxious Stimulus-Evoked Activity in the Ventral Posterolateral Nucleus of the Thalamus by a Cannabinoid Agonist: Correlation between Electrophysiological and Antinociceptive Effects. 16(20), 6601-6611.

R Mechoulam, D Panikashvili, E Shohami (2002) Cannabinoids and brain injury: therapeutic implications. 8(2), 58-61.

R Morris, P Garrud, J Rawlins, O' Keefe, J (1982) Place navigation impaired in rats with hippocampal lesions. 297(5868), 681-683.

Harrison Pope, D Yurgelun-Todd (1996) The Residual Cognitive Effects of Heavy Marijuana Use in College Students. 275(7), 521.

Y Sarne, F Asaf, M Fishbein, M Gafni, Keren (2011) The dual neuroprotective-neurotoxic profile of cannabinoid drugs. 163(7), 1391-1401.

Y Sarne, Keren (2004) Are cannabinoid drugs neurotoxic or neuroprotective?. 63(2), 187-192.

Andrew Scallet (1991) Neurotoxicology of cannabis and THC: A review of chronic exposure studies in animals. 40(3), 671-676.

A Schweinsburg, S Brown, S Tapert (2008) The influence of marijuana use on neurocognitive functioning in adolescents. 1(1), 99-111.

M Shen, S Thayer (1998) Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity. 54(3), 459-462.

Nadia Solowij, Patricia Michie, Allison Fox (1995) Differential impairments of selective attention due to frequency and duration of cannabis use. 37(10), 731-739.

Alexander Stiglick, Harold Kalant (1982) Residual effects of prolonged cannabis administration on exploration and DRL performance in rats. 77(2), 124-128.

Alexander Stiglick, Mark Llewellyn, Harold Kalant (1984) Residual effects of prolonged cannabis treatment on shuttle-box avoidance in the rat. 84(4), 476-479.